(-)-demecolcine increases expression ISO RGD:737308 6480464 Demecolcine results in increased expression of INHBE mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO RGD:732636 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of INHBE mRNA CTD PMID:36331819 1,4-dithiothreitol increases expression ISO RGD:737308 6480464 Dithiothreitol results in increased expression of INHBE mRNA CTD PMID:22935518 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression ISO RGD:737308 6480464 chlorcyclizine results in increased expression of INHBE mRNA CTD PMID:15342952 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile increases expression ISO RGD:737308 6480464 Citalopram results in increased expression of INHBE mRNA CTD PMID:17567588 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of INHBE mRNA CTD PMID:25380136 1-naphthyl isothiocyanate increases expression ISO RGD:737308 6480464 1-Naphthylisothiocyanate results in increased expression of INHBE mRNA CTD PMID:17175557 17alpha-ethynylestradiol affects expression ISO RGD:737308 6480464 Ethinyl Estradiol affects the expression of INHBE mRNA CTD PMID:20170705 17beta-estradiol multiple interactions ISO RGD:737308 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of INHBE mRNA, Estradiol promotes the reaction [ESR2 protein results in decreased expression of INHBE mRNA] CTD PMID:19619570 , PMID:20404318 17beta-estradiol decreases expression ISO RGD:737308 6480464 Estradiol results in decreased expression of INHBE mRNA CTD PMID:20106945 , PMID:21632981 17beta-estradiol increases expression ISO RGD:737308 6480464 Estradiol results in increased expression of INHBE mRNA CTD PMID:19619570 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:732636 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:737308 6480464 2 more ... CTD PMID:19095052 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:732636 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737308 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of INHBE mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of INHBE mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737308 6480464 Tetrachlorodibenzodioxin results in decreased expression of INHBE mRNA CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of INHBE mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732636 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of INHBE mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to INHBE promoter] CTD PMID:19654925 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732636 6480464 Tetrachlorodibenzodioxin results in decreased expression of INHBE mRNA CTD PMID:19770486 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:737308 6480464 2 more ... CTD PMID:26705709 3',5'-cyclic AMP multiple interactions ISO RGD:737308 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in decreased expression of INHBE mRNA CTD PMID:33713149 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:737308 6480464 tetrabromobisphenol A results in increased expression of INHBE mRNA CTD PMID:33476716 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of INHBE mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane decreases expression ISO RGD:732636 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of INHBE mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:737308 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of INHBE mRNA CTD PMID:25912373 , PMID:27685785 5-aza-2'-deoxycytidine affects expression ISO RGD:737308 6480464 Decitabine affects the expression of INHBE mRNA CTD PMID:23300844 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of INHBE mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of INHBE mRNA CTD PMID:19483382 acrylamide increases expression ISO RGD:737308 6480464 Acrylamide results in increased expression of INHBE mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:737308 6480464 Aflatoxin B1 affects the expression of INHBE protein CTD PMID:20106945 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of INHBE mRNA CTD PMID:33354967 aflatoxin B1 decreases expression ISO RGD:737308 6480464 Aflatoxin B1 results in decreased expression of INHBE mRNA CTD PMID:21632981 more ... aflatoxin B1 decreases expression ISO RGD:732636 6480464 Aflatoxin B1 results in decreased expression of INHBE mRNA CTD PMID:19770486 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of INHBE mRNA CTD PMID:19483382 amiodarone increases expression ISO RGD:737308 6480464 Amiodarone results in increased expression of INHBE mRNA CTD PMID:15342952 more ... amitriptyline increases expression ISO RGD:737308 6480464 Amitriptyline results in increased expression of INHBE mRNA CTD PMID:15342952 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of INHBE mRNA CTD PMID:16483693 arsenite(3-) affects expression ISO RGD:737308 6480464 arsenite affects the expression of INHBE mRNA CTD PMID:22959463 arsenous acid increases expression ISO RGD:737308 6480464 Arsenic Trioxide results in increased expression of INHBE mRNA CTD PMID:27829220 azoxystrobin decreases expression ISO RGD:737308 6480464 azoxystrobin results in decreased expression of INHBE mRNA CTD PMID:33512557 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of INHBE mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:732636 6480464 Benzo(a)pyrene results in decreased expression of INHBE mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:737308 6480464 Benzo(a)pyrene results in increased methylation of INHBE promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:737308 6480464 Benzo(a)pyrene results in decreased expression of INHBE mRNA CTD PMID:20106945 more ... beta-naphthoflavone increases expression ISO RGD:737308 6480464 beta-Naphthoflavone results in increased expression of INHBE mRNA CTD PMID:17175557 bis(2-chloroethyl) sulfide decreases expression ISO RGD:732636 6480464 Mustard Gas results in decreased expression of INHBE mRNA CTD PMID:15674843 bisphenol A affects expression ISO RGD:737308 6480464 bisphenol A affects the expression of INHBE mRNA CTD PMID:20170705 bisphenol A increases expression ISO RGD:737308 6480464 bisphenol A analog results in increased expression of INHBE mRNA CTD PMID:32387340 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of INHBE mRNA CTD PMID:30903817 bisphenol A decreases methylation ISO RGD:732636 6480464 bisphenol A results in decreased methylation of INHBE promoter CTD PMID:27312807 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of INHBE mRNA CTD PMID:25181051 bosentan affects expression ISO RGD:737308 6480464 Bosentan affects the expression of INHBE mRNA CTD PMID:29761207 carbamazepine affects expression ISO RGD:737308 6480464 Carbamazepine affects the expression of INHBE mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:732636 6480464 Nanotubes, Carbon affects the expression of INHBE mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:732636 6480464 Nanotubes, Carbon analog results in increased expression of INHBE mRNA CTD PMID:25620056 chlorpromazine increases expression ISO RGD:737308 6480464 Chlorpromazine results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17175557 choline multiple interactions ISO RGD:732636 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of INHBE mRNA, PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of INHBE mRNA] CTD PMID:29246445 ciguatoxin CTX1B affects expression ISO RGD:732636 6480464 Ciguatoxins affects the expression of INHBE mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of INHBE mRNA CTD PMID:22023808 cisplatin affects expression ISO RGD:737308 6480464 Cisplatin affects the expression of INHBE mRNA CTD PMID:23300844 citalopram increases expression ISO RGD:737308 6480464 Citalopram results in increased expression of INHBE mRNA CTD PMID:17567588 clarithromycin increases expression ISO RGD:737308 6480464 Clarithromycin results in increased expression of INHBE mRNA CTD PMID:15342952 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of INHBE mRNA CTD PMID:19483382 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of INHBE mRNA CTD PMID:15033592 clomipramine increases expression ISO RGD:737308 6480464 Clomipramine results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17175557 clozapine increases expression ISO RGD:737308 6480464 Clozapine results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17175557 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of INHBE mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:737308 6480464 cobaltous chloride results in increased expression of INHBE mRNA CTD PMID:22941251 cyclosporin A increases expression ISO RGD:737308 6480464 Cyclosporine results in increased expression of INHBE mRNA CTD PMID:19159671 more ... cyclosporin A decreases expression ISO RGD:737308 6480464 Cyclosporine results in decreased expression of INHBE mRNA CTD PMID:27989131 cyclosporin A affects expression ISO RGD:737308 6480464 Cyclosporine affects the expression of INHBE mRNA CTD PMID:20106945 , PMID:25562108 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of INHBE mRNA CTD PMID:23640034 diarsenic trioxide increases expression ISO RGD:737308 6480464 Arsenic Trioxide results in increased expression of INHBE mRNA CTD PMID:27829220 dicrotophos increases expression ISO RGD:737308 6480464 dicrotophos results in increased expression of INHBE mRNA CTD PMID:28302478 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of INHBE mRNA CTD PMID:16122865 disodium selenite increases expression ISO RGD:737308 6480464 Sodium Selenite results in increased expression of INHBE mRNA CTD PMID:24383545 dorsomorphin multiple interactions ISO RGD:737308 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxepin increases expression ISO RGD:737308 6480464 Doxepin results in increased expression of INHBE mRNA CTD PMID:17567588 entinostat increases expression ISO RGD:737308 6480464 entinostat results in increased expression of INHBE mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:737308 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INHBE mRNA CTD PMID:27188386 epoxiconazole affects expression ISO RGD:732636 6480464 epoxiconazole affects the expression of INHBE mRNA CTD PMID:35436446 erythromycin A increases expression ISO RGD:737308 6480464 Erythromycin results in increased expression of INHBE mRNA CTD PMID:17175557 ethanol multiple interactions ISO RGD:737308 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of INHBE mRNA CTD PMID:23378141 ethyl methanesulfonate increases expression ISO RGD:737308 6480464 Ethyl Methanesulfonate results in increased expression of INHBE mRNA CTD PMID:23649840 flecainide increases expression ISO RGD:737308 6480464 Flecainide results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17175557 fluoxetine increases expression ISO RGD:737308 6480464 Fluoxetine results in increased expression of INHBE mRNA CTD PMID:15342952 more ... folic acid multiple interactions ISO RGD:737308 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of INHBE mRNA CTD PMID:23378141 formaldehyde increases expression ISO RGD:737308 6480464 Formaldehyde results in increased expression of INHBE mRNA CTD PMID:23649840 furan increases expression ISO RGD:732636 6480464 furan results in increased expression of INHBE mRNA CTD PMID:24183702 genistein increases expression ISO RGD:737308 6480464 Genistein results in increased expression of INHBE mRNA CTD PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of INHBE mRNA CTD PMID:33387578 haloperidol increases expression ISO RGD:737308 6480464 Haloperidol results in increased expression of INHBE mRNA CTD PMID:17175557 hydrazine increases expression ISO RGD:732636 6480464 hydrazine results in increased expression of INHBE mRNA CTD PMID:15282401 hydroquinone decreases expression ISO RGD:737308 6480464 hydroquinone results in decreased expression of INHBE mRNA CTD PMID:29221148 imipramine increases expression ISO RGD:737308 6480464 Imipramine results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17567588 inulin multiple interactions ISO RGD:732636 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of INHBE mRNA CTD PMID:36331819 isoniazide increases expression ISO RGD:737308 6480464 Isoniazid results in increased expression of INHBE mRNA CTD PMID:17175557 ketoconazole increases expression ISO RGD:737308 6480464 Ketoconazole results in increased expression of INHBE mRNA CTD PMID:15342952 more ... L-1,4-dithiothreitol increases expression ISO RGD:737308 6480464 Dithiothreitol results in increased expression of INHBE mRNA CTD PMID:22935518 L-ascorbic acid multiple interactions ISO RGD:737308 6480464 [BDNF protein co-treated with GDNF protein co-treated with Cyclic AMP co-treated with TGFB3 protein co-treated with Ascorbic Acid] results in decreased expression of INHBE mRNA CTD PMID:33713149 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of INHBE mRNA CTD PMID:19483382 lead diacetate increases expression ISO RGD:732636 6480464 lead acetate results in increased expression of INHBE mRNA CTD PMID:22609695 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of INHBE mRNA CTD PMID:24136188 leflunomide increases expression ISO RGD:737308 6480464 leflunomide results in increased expression of INHBE mRNA CTD PMID:28988120 Licochalcone B decreases expression ISO RGD:737308 6480464 licochalcone B results in decreased expression of INHBE mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in decreased expression of INHBE mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions ISO RGD:737308 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of INHBE mRNA CTD PMID:35811015 loratadine increases expression ISO RGD:737308 6480464 Loratadine results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17567588 mercury dibromide increases expression ISO RGD:737308 6480464 mercuric bromide results in increased expression of INHBE mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:737308 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INHBE mRNA CTD PMID:27188386 metacetamol decreases expression ISO RGD:732636 6480464 3-hydroxyacetanilide results in decreased expression of INHBE mRNA CTD PMID:18544908 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of INHBE mRNA CTD PMID:30467583 methyl methanesulfonate increases expression ISO RGD:737308 6480464 Methyl Methanesulfonate results in increased expression of INHBE mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:737308 6480464 methylmercuric chloride results in increased expression of INHBE mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium increases expression ISO RGD:737308 6480464 1-Methyl-4-phenylpyridinium results in increased expression of INHBE mRNA CTD PMID:24810058 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of INHBE mRNA CTD PMID:19638242 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of INHBE mRNA CTD PMID:17072980 , PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:737308 6480464 N-Nitrosopyrrolidine results in decreased expression of INHBE mRNA CTD PMID:32234424 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in decreased expression of INHBE mRNA CTD PMID:16415329 nelfinavir increases expression ISO RGD:737308 6480464 Nelfinavir results in increased expression of INHBE mRNA CTD PMID:22935518 nevirapine decreases expression EXP 6480464 Nevirapine metabolite results in decreased expression of INHBE mRNA CTD PMID:23947594 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of INHBE mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of INHBE mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:737308 6480464 methyleugenol results in decreased expression of INHBE mRNA CTD PMID:32234424 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of INHBE mRNA CTD PMID:19483382 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of INHBE mRNA CTD PMID:23439660 p-chloromercuribenzoic acid increases expression ISO RGD:737308 6480464 p-Chloromercuribenzoic Acid results in increased expression of INHBE mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:737308 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INHBE mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:737308 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INHBE mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:737308 6480464 panobinostat results in increased expression of INHBE mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:732636 6480464 Acetaminophen results in decreased expression of INHBE mRNA CTD PMID:18544908 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of INHBE mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:737308 6480464 Acetaminophen results in decreased expression of INHBE mRNA CTD PMID:17175557 , PMID:21420995 paracetamol increases expression ISO RGD:737308 6480464 Acetaminophen results in increased expression of INHBE mRNA CTD PMID:17175557 paracetamol affects expression ISO RGD:732636 6480464 Acetaminophen affects the expression of INHBE mRNA CTD PMID:17562736 parathion decreases expression ISO RGD:732636 6480464 Parathion results in decreased expression of INHBE mRNA CTD PMID:34813904 PCB138 multiple interactions ISO RGD:732636 6480464 [2 more ... CTD PMID:25510870 pentamidine increases expression ISO RGD:737308 6480464 Pentamidine results in increased expression of INHBE mRNA CTD PMID:15342952 perfluorononanoic acid increases expression ISO RGD:737308 6480464 perfluoro-n-nonanoic acid results in increased expression of INHBE mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of INHBE mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732636 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of INHBE mRNA more ... CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:737308 6480464 perfluorooctanoic acid results in increased expression of INHBE mRNA CTD PMID:32588087 , PMID:36326898 perhexiline increases expression ISO RGD:737308 6480464 Perhexiline results in increased expression of INHBE mRNA CTD PMID:17175557 phenformin increases expression EXP 6480464 Phenformin results in increased expression of INHBE mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:732636 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of INHBE mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:732636 6480464 Phenobarbital affects the expression of INHBE mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:737308 6480464 Phenobarbital results in increased expression of INHBE mRNA CTD PMID:17175557 phenobarbital increases expression ISO RGD:732636 6480464 Phenobarbital results in increased expression of INHBE mRNA CTD PMID:19270015 phenobarbital decreases expression ISO RGD:732636 6480464 Phenobarbital results in decreased expression of INHBE mRNA CTD PMID:19482888 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of INHBE mRNA CTD PMID:19162173 phenylmercury acetate increases expression ISO RGD:737308 6480464 Phenylmercuric Acetate results in increased expression of INHBE mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737308 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INHBE mRNA CTD PMID:27188386 pirinixic acid affects expression ISO RGD:732636 6480464 pirinixic acid affects the expression of INHBE mRNA CTD PMID:18445702 pirinixic acid decreases expression ISO RGD:732636 6480464 pirinixic acid results in decreased expression of INHBE mRNA CTD PMID:23811191 pirinixic acid increases expression ISO RGD:732636 6480464 pirinixic acid results in increased expression of INHBE mRNA CTD PMID:18301758 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of INHBE mRNA CTD PMID:19162173 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of INHBE mRNA CTD PMID:19483382 pirinixic acid multiple interactions ISO RGD:732636 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of INHBE mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:732636 6480464 Pregnenolone Carbonitrile results in decreased expression of INHBE mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:732636 6480464 propiconazole results in decreased expression of INHBE mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:737308 6480464 Quercetin results in decreased expression of INHBE mRNA CTD PMID:21632981 quinidine increases expression ISO RGD:737308 6480464 Quinidine results in increased expression of INHBE mRNA CTD PMID:15342952 quinolin-8-ol decreases expression ISO RGD:737308 6480464 Oxyquinoline results in decreased expression of INHBE mRNA CTD PMID:21632981 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in decreased expression of INHBE mRNA CTD PMID:16415329 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of INHBE mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:737308 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of INHBE mRNA CTD PMID:33725128 , PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:737308 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of INHBE mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:737308 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sertraline increases expression ISO RGD:737308 6480464 Sertraline results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17567588 silver atom increases expression ISO RGD:737308 6480464 Silver results in increased expression of INHBE mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:737308 6480464 Silver results in increased expression of INHBE mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO RGD:737308 6480464 sodium arsenite results in decreased expression of INHBE mRNA CTD PMID:29301061 sodium arsenite increases expression ISO RGD:737308 6480464 sodium arsenite results in increased expression of INHBE mRNA CTD PMID:34032870 sotalol decreases expression ISO RGD:737308 6480464 Sotalol results in decreased expression of INHBE mRNA CTD PMID:17175557 sotalol increases expression ISO RGD:737308 6480464 Sotalol results in increased expression of INHBE mRNA CTD PMID:17175557 sunitinib increases expression ISO RGD:737308 6480464 Sunitinib results in increased expression of INHBE mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:732636 6480464 Tamoxifen affects the expression of INHBE mRNA CTD PMID:20937368 tamoxifen increases expression ISO RGD:737308 6480464 Tamoxifen results in increased expression of INHBE mRNA CTD PMID:17175557 , PMID:17567588 tebuconazole decreases expression ISO RGD:737308 6480464 tebuconazole results in decreased expression of INHBE mRNA CTD PMID:30458266 temozolomide increases expression ISO RGD:737308 6480464 Temozolomide results in increased expression of INHBE mRNA CTD PMID:31758290 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of INHBE mRNA CTD PMID:21515302 tetrachloromethane increases expression ISO RGD:732636 6480464 Carbon Tetrachloride results in increased expression of INHBE mRNA CTD PMID:25827057 tetrachloromethane decreases expression ISO RGD:732636 6480464 Carbon Tetrachloride results in decreased expression of INHBE mRNA CTD PMID:31919559 tetracycline increases expression ISO RGD:737308 6480464 Tetracycline results in increased expression of INHBE mRNA CTD PMID:17175557 thapsigargin increases expression ISO RGD:737308 6480464 Thapsigargin results in increased expression of INHBE mRNA CTD PMID:22935518 thifluzamide increases expression ISO RGD:737308 6480464 thifluzamide results in increased expression of INHBE mRNA CTD PMID:33512557 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of INHBE mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of INHBE mRNA CTD PMID:23411599 , PMID:34492290 thioridazine increases expression ISO RGD:737308 6480464 Thioridazine results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17175557 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of INHBE mRNA CTD PMID:33387578 triptonide increases expression ISO RGD:732636 6480464 triptonide results in increased expression of INHBE mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:737308 6480464 troglitazone results in decreased expression of INHBE mRNA CTD PMID:25572481 tunicamycin increases expression ISO RGD:737308 6480464 Tunicamycin results in increased expression of INHBE mRNA CTD PMID:22935518 more ... urethane decreases expression ISO RGD:737308 6480464 Urethane results in decreased expression of INHBE mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of INHBE mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:732636 6480464 Valproic Acid affects the expression of INHBE mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:737308 6480464 Valproic Acid results in decreased expression of INHBE mRNA CTD PMID:29154799 valproic acid increases expression ISO RGD:737308 6480464 Valproic Acid results in increased expression of INHBE mRNA CTD PMID:17175557 , PMID:23179753 valproic acid affects expression ISO RGD:737308 6480464 Valproic Acid affects the expression of INHBE mRNA CTD PMID:25979313 vincristine increases expression ISO RGD:737308 6480464 Vincristine results in increased expression of INHBE mRNA CTD PMID:23649840 zimeldine increases expression ISO RGD:737308 6480464 Zimeldine results in increased expression of INHBE mRNA CTD PMID:15342952 , PMID:17175557 zoledronic acid increases expression ISO RGD:737308 6480464 zoledronic acid results in increased expression of INHBE mRNA CTD PMID:20977926